Group 1: Liquor Industry Analysis - The report indicates that the pressure on the liquor industry has passed, with leading companies clarifying their long-term strategies and shifting from passive to proactive tactics [17][20] - The report highlights that the overall performance of the liquor industry during the Spring Festival was better than expected, with key products from leading companies showing good performance [20] - The report anticipates that the price of Moutai will stabilize above 1500 yuan, confirming the expectation of a turning point in the industry cycle [20] Group 2: Luzhou Laojiao (000568) Analysis - Luzhou Laojiao is recognized for its comprehensive competitive advantages in team capability, management level, incentive mechanisms, brand strength, product structure, and channel capabilities, positioning it as a "hexagonal warrior" in the liquor sector [3][11] - The company is expected to see its performance bottom out in the short term, with stable pricing strategies in place, aiming to reduce channel inventory and improve financial statements [11][13] - By 2030, the revenue potential for Luzhou Laojiao is projected to reach 40 billion yuan, with significant contributions from its high-end products [13][14] Group 3: Crystal International (02232) Analysis - Crystal International is positioned as a diversified international garment manufacturer, deeply integrated with top global brand clients, enhancing profitability through vertical integration [3][12] - The company is expected to benefit from a significant increase in customer orders, particularly from major clients like Uniqlo, Nike, and Adidas, while also expanding into the outdoor and sportswear sectors [12][16] - The report projects a steady increase in net profit for Crystal International from 2.5 billion to 3.0 billion USD from 2026 to 2028, with a "buy" rating assigned [16] Group 4: Shijia Photon (688313) Analysis - Shijia Photon is a leading domestic manufacturer of optical chips and devices, benefiting from the AI-driven demand for AWG and MPO products, with revenue reaching 1.56 billion yuan in the first three quarters of 2025, a year-on-year increase of 114% [3][15] - The company is expected to capitalize on the growing demand for high-density connections in AI data centers, with plans to enhance its supply chain through strategic acquisitions [15][16] - The report assigns a "buy" rating to Shijia Photon, anticipating significant revenue growth from 2.13 billion to 4.09 billion yuan from 2025 to 2027 [15][16] Group 5: Food and Beverage Industry Insights - The report concludes that the food and beverage sector is showing structural improvements, with competition shifting from price to quality, and a gradual balance in supply and demand [20] - The report emphasizes the potential for recovery in consumer prices, particularly in the liquor and food sectors, as companies adapt to changing market conditions [20] - Key recommendations include focusing on cyclical food and beverage companies with growth potential, such as Anjuke Food and Haitian Flavoring [20]

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry [2] Core Insights - The cosmetics and medical beauty sector has underperformed the market recently, with the Shenwan Beauty Care Index declining by 4.8% from March 13 to March 20, 2026, which is 0.7 percentage points worse than the Shenwan A Index [4][5] - Upcoming earnings reports from key companies such as Lin Qingxuan and Shangmei will be critical to monitor [4][10] - The report highlights the performance of major companies, noting that Aimeike's revenue for 2025 is projected at 2.453 billion yuan, a year-on-year decrease of 18.94% [11] Summary by Sections Industry Performance - The Shenwan Cosmetics Index fell by 3.4%, while the Shenwan Personal Care Index dropped by 4.4%, indicating varied performance within the sector [4][5] - The report notes that the beauty care sector is entering earnings season, with several companies set to announce their financial results [10] Company Highlights - Aimeike's 2025 performance shows a revenue of 2.453 billion yuan, down 18.94% year-on-year, with a net profit of 1.291 billion yuan, down 34.05% [11] - Juzi Biotechnology reported a slight revenue decline of 0.4% to 5.519 billion yuan, with a net profit decrease of 7.2% [11] - The report emphasizes the importance of product matrix improvement and collaboration for growth in Aimeike's future performance [12] Market Trends - The report indicates that the retail sales of cosmetics in China grew by 4.5% year-on-year in the first two months of 2026, outperforming overall retail growth [16] - The report also notes that the domestic market is seeing a shift towards local brands, with significant growth in market share for domestic products [23] Industry Dynamics - The report discusses the strategic partnership between L'Oréal and NVIDIA to enhance AI research in beauty products, reflecting a trend towards technological integration in the industry [20] - The competitive landscape is evolving, with domestic brands gaining ground against international players, particularly in the skincare segment [23]

Investment Rating - The report maintains a "Buy" rating for the cosmetics and medical beauty sector, highlighting the potential for growth despite recent underperformance compared to the market [2]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with the Shenwan Beauty Care Index declining by 3.0% from February 27 to March 6, 2026. The Shenwan Cosmetics Index fell by 4.9%, underperforming the Shenwan A Index by 2.5 percentage points [3][2]. - Upbeauty Co., Ltd. has reported a positive earnings forecast for 2025, with expected revenue between 9.1 billion and 9.2 billion yuan, representing a year-on-year increase of 34.0% to 35.4%. The expected net profit attributable to shareholders is projected to be between 1.14 billion and 1.16 billion yuan, reflecting a growth of 41.9% to 44.4% [8][2]. - The report emphasizes the strong brand and product capabilities of Upbeauty, which are expected to support its performance in the short term, while its diversified layout and solid industry barriers are seen as beneficial for long-term growth [8][2]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has underperformed the market recently, with specific indices showing declines [3][2]. - The report notes that the overall retail sales of cosmetics in December 2025 grew by 8.8%, indicating a recovery in consumer spending [16][19]. Company Highlights - Upbeauty Co., Ltd. is highlighted for its strong performance, with a focus on anti-aging products that align with consumer trends towards domestic brands [8][2]. - Huaxi Biological's earnings report indicates a net profit of 291 million yuan for 2025, a significant increase of 67.03% year-on-year, showcasing the effectiveness of its strategic transformation [2][21]. - Yatsen E-commerce reported a revenue of 1.38 billion yuan in Q4 2025, marking a 20.1% increase year-on-year, with skincare being the main growth driver [21][2]. Market Trends - The report identifies a structural growth phase in the nutrition and health food market, with a focus on functional foods and sports nutrition as key growth areas [10][9]. - The Chinese skincare market is projected to reach 271.2 billion yuan in 2024, despite a slight decline of 3.7% year-on-year, with domestic brands gaining market share [25][26]. E-commerce Insights - The report highlights the dominance of online channels in driving growth within the industry, with a significant portion of revenue coming from direct-to-consumer (DTC) sales [10][9]. - The performance of various domestic brands in e-commerce platforms is noted, with Upbeauty showing substantial growth in its online sales [13][2].

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, suggesting a focus on pre-festival promotions as a key opportunity for growth [3][10]. Core Insights - The cosmetics and medical beauty sector has underperformed the market recently, with the Shenwan Beauty Care Index declining by 3.8% from January 23 to January 30, 2026, which is worse than the overall market performance [4][5]. - Recent earnings forecasts from companies like Shanghai Jahwa, Ruya Chen, and Huaxi Biological indicate a recovery in profitability, highlighting the sector's high growth potential [10][11]. - The upcoming Spring Festival is expected to drive significant promotional activities, particularly on platforms like Tmall and Douyin, which could enhance sales for domestic brands [10][11]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown a decline, with the Shenwan Cosmetics Index down 3.6% and the Shenwan Personal Care Index down 4.6%, both underperforming the Shenwan A Index [4][5]. - The top-performing stocks in the sector include Qingdao Kingway (+7.2%) and Beijia Clean (+0.1%), while the worst performers include Lafang Jiahua (-18.7%) and Shanghai Jahwa (-10.9%) [6]. Earnings Forecasts - Companies like Ruya Chen expect a net profit of 176 to 200 million yuan for 2025, representing a year-on-year increase of 66.61% to 89.33% [4]. - Shanghai Jahwa anticipates a turnaround with a projected net profit of 240 to 290 million yuan for 2025, while Huaxi Biological expects a net profit of 270 to 320 million yuan, reflecting a growth of 54.93% to 83.63% [4][10]. Market Trends - The retail sales of cosmetics in 2025 are projected to grow by 5.1%, with a notable increase in Q4 driven by promotional events like Double Eleven [11][19]. - The report highlights the strong performance of domestic brands, with significant growth in online sales channels, particularly on Douyin [12][29]. Investment Recommendations - Key recommendations include focusing on brands with strong growth in GMV such as Mao Ge Ping, Shangmei Co., and Shanghai Jahwa, as well as companies in the medical beauty sector like Aimeike and Langzi Co. [14][30]. - The report also suggests monitoring e-commerce operations and self-owned brands like Ruya Chen and Qingmu Technology for potential high growth [14][30].

Overview - The report indicates a marginal improvement in the performance of public REITs in Q4 2025, with significant growth in public utility and consumer revenue, while industrial parks and warehousing have shifted from negative to positive growth. EBITDA declines in energy and transportation sectors have narrowed, and rental housing performance has faced slight pressure. The completion rates for distributable amounts of newly issued REITs for 2024 and 2025 are 79% and 64% respectively [2][13]. Consumer Sector - The consumer sector has shown strong performance during the peak season, with improvements in rental rates and occupancy across most projects. Two-thirds of the projects achieved their highest revenue in the last five periods, indicating overall strong performance [2][13]. Rental Housing - The overall occupancy rate in the rental housing sector remains high, but rental performance is mixed. Government-led projects have stabilized both volume and price, while market-driven projects have adjusted prices downward to maintain occupancy [2][13]. Public Utilities - The public utility sector has seen significant revenue growth due to an increase in waste sources for biomass projects. However, the heating supply in Jinan has underperformed expectations, and water-related projects have experienced seasonal declines [2][13]. Energy Sector - The energy sector is experiencing increased differentiation, with fluctuating power generation and generally declining electricity prices. Natural gas projects are under the most pressure, with EBITDA margins dropping to negative values, while offshore wind and photovoltaic projects remain stable [3][13]. IDC Sector - The IDC sector benefits from long-term contracts with major clients, leading to stable volume and price. The distribution amounts for IDC in Q4 2025 have seen significant growth [3][13]. Transportation Sector - Traffic volume in the transportation sector is influenced by changes in surrounding road networks. Some projects have benefited from traffic recovery due to completed construction, while others continue to face diversion pressures, leading to varied performance [3][13]. Warehousing and Logistics - The warehousing and logistics sector has seen a widening decline in rental rates for market-oriented leasing projects, but this has effectively driven an increase in occupancy rates. Overall, the industry is exhibiting a trend of "price for volume" [3][13]. Industrial Parks - The industrial park market is showing weak recovery and strong differentiation. Commercial office projects are facing significant rental pressure, while manufacturing parks have maintained stable revenue but experienced a general decline in EBITDA [3][13]. Cosmetics and Aesthetic Medicine Sector - The cosmetics sector is expected to see steady growth in brand performance, with retail sales of cosmetics projected to reach 4,653 billion yuan in 2025, a year-on-year increase of 5.1%, outperforming the overall retail market by 1.4 percentage points [14][16]. - Key players in the Hong Kong stock market, such as Up Beauty and Mao Ge Ping, are expected to report significant growth in GMV, driven by strong performance on platforms like Douyin during promotional events [14][16]. E-commerce and Agency Operations - The e-commerce agency sector is experiencing a resurgence, with companies like Yi Wan Yi Chuang and Shui Yang Co. expected to see substantial profit growth due to improved operational efficiency and brand development [16][16].

Investment Rating - The report rates the cosmetics and medical beauty industry as "Overweight" for 2025, indicating an expectation for the industry to outperform the overall market [2][11]. Core Insights - The demand side of the cosmetics and medical beauty sector is expected to accelerate, with retail sales of cosmetics projected to reach 465.3 billion yuan in 2025, a year-on-year growth of 5.1%, surpassing the overall retail growth by 1.4 percentage points [3]. - The performance of Hong Kong-listed beauty companies is strong, with significant growth in GMV (Gross Merchandise Volume) through platforms like Douyin, particularly during promotional events like Double Eleven [3]. - The A-share market shows a mixed performance, with companies like Ruoyuchen and Shanghai Jahwa experiencing substantial improvements in their earnings [3]. - The e-commerce operation sector is rebounding, with companies like Ruoyuchen and Yiwang Yichuang expected to see profit growth exceeding 50% in 2025 [3]. - The medical beauty segment is anticipated to face slight fatigue due to macroeconomic factors, but new product launches are expected to stimulate consumer interest in 2026 [3]. Summary by Sections Cosmetics Sector - Retail sales of cosmetics are projected to grow by 5.1% in 2025, with Q4 growth reaching 9.9% [3]. - Key companies such as Shiseido and Lin Qingxuan are expected to see significant GMV growth, with Lin Qingxuan projected to achieve triple-digit growth [3]. - Investment recommendations include companies with strong channel and brand matrices like Maogeping, Shiseido, and Lin Qingxuan, as well as those with improving earnings like Porlaia and Marubi [3]. Medical Beauty Sector - The medical beauty sector is expected to be impacted by macroeconomic conditions, with companies like Aimeike facing challenges [3]. - Recommendations focus on companies with strong R&D capabilities and broad product pipelines, such as Aimeike and Langzi [3]. E-commerce and Operations - The e-commerce operation sector is recovering, with companies like Ruoyuchen and Qingmu Technology expected to see significant profit growth [3]. - The report highlights the importance of self-operated brands and the potential for high growth in this segment [3]. Key Company Valuations - The report provides a valuation table for key companies, indicating a "Buy" rating for several firms including Porlaia, Maogeping, and Shiseido, with projected PE ratios reflecting growth expectations [5].

Investment Rating - The report indicates a positive investment outlook for the cosmetics and medical beauty sector, highlighting strong performance relative to the market [2][3]. Core Insights - The cosmetics and medical beauty sector has shown resilience, with the Shenwan Beauty Care Index rising by 2.9% from December 12 to December 19, 2025, outperforming the market [2][3]. - Lin Qingxuan, a leading high-end plant skincare brand, is preparing for its IPO in Hong Kong, with a focus on its core product, camellia oil, which has sold over 30 million bottles [2][6]. - Minooxidil products from Mandi International dominate the hair growth market, with a market share of approximately 57% in the hair loss treatment sector [7][10]. Summary by Sections Industry Performance - The Shenwan Cosmetics Index increased by 2.2%, outperforming the Shenwan A Index by 2.4 percentage points, while the Shenwan Personal Care Index rose by 4.4%, exceeding the Shenwan A Index by 4.6 percentage points [2][3]. - Top-performing stocks included Hongmian Co. (+16.2%), Jiaheng Jiahua (+11.4%), and Baiya Co. (+9.1%) [3]. Company Highlights - Lin Qingxuan's product matrix includes 188 SKUs, with camellia oil accounting for 37% of revenue in 2024, while face creams and masks contribute 15.7% and 12.2%, respectively [6]. - Mandi International's revenue is projected to grow from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, with a CAGR of 21.7% [8]. - The company has maintained a leading position in the minoxidil market for ten consecutive years, with a market share of 71% in 2024 [10]. Market Trends - The Chinese consumer healthcare market is expected to grow from 9.313 billion yuan in 2018 to 16.420 billion yuan in 2024, with a CAGR of 9.9% [9]. - The hair health management market is projected to grow at a CAGR of 17.7% from 2018 to 2024, while the weight management drug market is expected to grow at 20.7% during the same period [9]. E-commerce Insights - The report highlights significant growth in online sales channels, with Lin Qingxuan's online revenue increasing by 81.1%, contributing to 59.1% of total revenue [6]. - The overall cosmetics retail sales in China for the first 11 months of 2025 reached 428.5 billion yuan, with a year-on-year growth of 4.8% [14][15]. Strategic Developments - Proya has invested in the cosmetic raw material company Huaguan Biotechnology to enhance its capabilities in the whitening market, which is projected to exceed 150 billion yuan by 2027 [16][19]. - The report emphasizes the importance of product innovation and market positioning for domestic brands, which are gaining market share against international competitors [22].

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, highlighting strong performance in the sector [2]. Core Insights - The cosmetics and medical beauty sector outperformed the market, with the Shenwan Beauty Care Index rising by 2.9% from December 12 to December 19, 2025, surpassing the Shenwan A Index by 2.4 percentage points [3][4]. - Lin Qingxuan, a leading high-end plant skincare brand, is set to launch its IPO in Hong Kong, with a focus on its core product, camellia oil, which has sold over 30 million bottles [9]. - Minooxidil products from Mandi International dominate the hair growth market, with a market share of approximately 57% in the hair loss treatment sector [10][13]. - Proya has invested in a cosmetic raw material company, Huaguan Biotechnology, to enhance its whitening product offerings, targeting a market expected to exceed 150 billion yuan by 2027 [19][22]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector showed strong performance, with the Shenwan Beauty Care Index increasing by 2.9% during the specified period, outperforming the Shenwan A Index [3][4]. Company Highlights - Lin Qingxuan's product matrix includes 188 SKUs, with camellia oil contributing 37% to revenue in 2024, while offline channels are expected to generate 40.9% of revenue [9]. - Mandi International's revenue grew from 982 million yuan in 2022 to approximately 1.455 billion yuan in 2024, with a CAGR of 21.7% [11]. - Proya's strategic investment in Huaguan Biotechnology aims to capture a significant share of the whitening market, with new product launches and patent approvals [19][22]. Market Trends - The Chinese consumer healthcare market is projected to grow from 931.3 billion yuan in 2018 to 1.642 trillion yuan in 2024, driven by increased health awareness and digital transformation [12]. - The hair health management market is expected to grow at a CAGR of 17.7% from 2018 to 2024, indicating strong demand for hair loss treatments [12][13]. - The overall retail sales of cosmetics in China reached 428.5 billion yuan in the first eleven months of 2025, with a year-on-year growth of 4.8% [17][18].

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, highlighting strong performance in the sector [2]. Core Insights - The cosmetics and medical beauty sector outperformed the market, with the Shenwan Beauty Care Index rising by 3.7% from November 7 to November 14, 2025, surpassing the market average [3][4]. - The Double 11 shopping festival saw significant sales for domestic brands, with Proya leading sales on Tmall for three consecutive years, indicating a sustained rise of domestic brands [9][30]. - Proya has re-entered the men's skincare market, launching a new product line aimed at addressing various skincare needs, which is seen as a strategic move to enhance revenue and compete with international brands [30]. - Marubi Biotech announced plans for an H-share listing in Hong Kong to strengthen its capital base and international strategy, following similar moves by other domestic beauty brands [31]. Summary by Sections Industry Performance - The Shenwan Beauty Care Index increased by 3.7%, with the cosmetics index up by 2.5% and personal care index up by 3.7%, indicating strong sector performance [3][4]. - The Double 11 sales event resulted in high single-digit growth in online GMV for beauty products, second only to home appliances and clothing [9]. Key Company Developments - Proya's Q3 2025 revenue reached 7.098 billion yuan, a year-on-year increase of 1.89%, with a net profit of 1.026 billion yuan, reflecting a stable performance despite a slight decline in Q3 [10][11]. - Marubi Biotech's revenue for the first three quarters of 2025 was 2.45 billion yuan, a 25.51% increase year-on-year, indicating strong growth potential [31]. Market Trends - The cosmetics retail sector saw a 9.6% year-on-year growth in October 2025, driven by the Double 11 shopping festival, which boosted consumer demand [25][27]. - Domestic brands are gaining market share, with Proya and other local brands performing well against international competitors [34]. E-commerce Insights - Data from October 2025 shows that Proya achieved a GMV of 21.5 billion yuan across Tmall and Douyin, despite a 9% decline year-on-year, indicating resilience in a competitive market [24]. - The report highlights the importance of e-commerce channels for domestic brands, which are leveraging their advantages in pricing and local market insights to capture market share [34].

Group 1: Key Insights on the Liquor Industry - The liquor industry is entering a strategic layout period as it approaches a bottom, with a bullish outlook for high-quality companies [2][10] - Historical performance from 2012 to 2015 indicates that stock price turning points precede fundamental turning points, with expectations for a fundamental turning point in Q3 2026 [2][10] - If the fundamentals recover as anticipated, a dual boost in valuation and performance is expected from late 2026 to 2027 [2][10] - Recommended stocks include Luzhou Laojiao, Shanxi Fenjiu, Kweichow Moutai, and Wuliangye, with additional attention on Yingjia Gongjiu and Jinhuijiu [2][10] Group 2: Analysis of the Cycle Industry Funds - Cycle industry funds can be categorized into five types: Cycle + Satellite, Sector Rotation, Sub-sector, Cycle Rotation, and Cycle Balance [10] - These funds have shown the ability to generate stable excess returns compared to sector indices over the long term [10] - The funds are particularly adept at stock selection in sectors such as public utilities, basic chemicals, oil and petrochemicals, and non-ferrous metals [10] Group 3: Insights on the Agricultural and Livestock Industry - The livestock sector is experiencing a decline in profitability, particularly in pig farming, with significant price drops leading to losses [18][21] - The overall agricultural sector saw a 11% increase in net profit year-on-year, with notable growth in animal health and agricultural product processing [18][21] - The pet food segment remains robust in domestic sales, with a 17.7% increase in revenue year-on-year, despite challenges in export due to tariffs [18][21] Group 4: Performance of the Cosmetics and Aesthetic Medicine Industry - The cosmetics sector has shown weaker performance compared to the market, with a 3.1% decline in the beauty care index [12][14] - The upcoming Double 11 shopping festival is expected to boost sales for companies like Up Beauty and Maogeping, with strong performance anticipated in their main brands [12][14] - Key recommendations include focusing on companies with strong channel and brand matrices, such as Maogeping and Up Beauty, as well as those with improving growth rates like Proya and Marubi [12][14]